For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Vanessa Hrvatin (Communications Coordinator) or Clement Woo (Communications Manager).

To keep in touch with the Centre and up-to-date on our research, follow us on Twitter or subscribe to Brain Matters, our monthly e-newsletter.

DMCBH Statement on Anti-racism and violence Jun 8, 2020

By now, nearly everyone has seen the horrific video of George Floyd being killed by Minneapolis police, an act that has sparked outrage and despair as we all grapple with the reality of injustice that the Black community faces around the world.  

COVID-19 series: The importance of exercise during a pandemic Jun 3, 2020

In the coming weeks, we will be profiling COVID-19 work and expertise from Djavad Mowafaghian Centre for Brain Health members. Our second story is about the importance of exercise, with expertise from DMCBH researcher Dr. Teresa Liu-Ambrose, Director of the Aging, Mobility, and Cognitive Neuroscience Lab.

COVID-19 Series: Dr. Stephanie Willerth's Lab Creates Face Shields for Frontline Workers May 25, 2020

In the coming weeks, we will be profiling COVID-19 work and expertise from Djavad Mowafaghian Centre for Brain Health members. Our first profile is DMCBH researcher Dr. Stephanie Willerth, Affiliate Professor at UBC's School of Biomedical Engineering, ICORD member and Acting Director of Biomedical Engineering at the University of Victoria. 

Community News: May 2020 May 22, 2020

Dr. Cheryl Wellington (pictured) is leading a team of researchers in characterizing changes in the immune system of COVID-19 infected patients. Her work has received a lot of media attention this month! 

New Study Shows Microbiome is Associated with Gut Function in Parkinson’s Disease May 6, 2020

Pictured (left to right) are Dr. Seti Boroomand, lead author Mihai Cirstea, co-author Kristen Sundvick, co-author Ella Golz, team lead Dr. Silke Cresswell, and research coordinator Adam Yu. 

Over the past decade, researchers have been studying the human microbiome—an array of microorganisms including bacteria, parasites, viruses, and fungi—to determine how it might be involved in disease. When it comes to Parkinson’s Disease (PD), most research has focused on defining the PD microbiome and attempting to link these microorganisms to neurological systems.

Supporting the mental health needs of those on front-lines May 6, 2020

Each day, health-care providers on the front lines of the COVID-19 outbreak are facing enormous pressure, caring for patients battling the disease, supporting those who have lost loved ones, and coping with the many ways the outbreak has touched their own home and family lives.

UBC’s Dr. Lakshmi Yatham, DMCBH member and head of the department of psychiatry, believes the outbreak could have a far-reaching toll on the mental health of health-care providers and their families.

Dr. Stan Floresco Receives UBC Killam Teaching Prize Apr 30, 2020

Dr. Stan Floresco has been awarded the UBC Killam Teaching Prize for his excellence in teaching. Dr. Floresco is a Professor in the Department of Psychology and his research program is based at the Djavad Mowafaghian Centre for Brain Health.

Community News: April 2020 Apr 27, 2020

Dr. Stephanie Willerth (pictured) and her lab have joined the fight against COVID-19 by producing face shields for frontline workers using 3D printers. 

Parkinson's Awareness Month: Highlighting Important Research at the DMCBH Apr 27, 2020

April is Parkinson’s awareness month, a time to shed light on a disease that affects more than 100,000 Canadians. At the Movement Disorders Clinic housed in the Djavad Mowafaghian Centre for Brain Health, neurologists and researchers are working together to develop creative ways of using technology to help Parkinson’s patients.


Pictured are Dr. Matthew Farrar and Hamid Eshghi, President of the Djavad Mowafaghian Foundation.

With a generous gift from the Djavad Mowafaghian Foundation, the UBC Faculty of Medicine has uncovered more gene mutations responsible for epilepsy in children who don’t respond to traditional therapies.